Details of the Drug

General Information of Drug (ID: DMAEBSO)

• Drug Name: Anti-T-lymphocyte immune globulin

Indication

Disease Entry	ICD 11	Status	REF
Graft-versus-host disease	4B24	Phase 3	[1]

• Cross-matching ID: TTD ID: D0WQ0R

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)